Form EFFECT Benitec Biopharma Inc.
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | June 2, 2025 4:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- STARCORE Reports First Quarter Production Results
- Ress Life Investments A/S publishes Net Asset Value (NAV).
- SAGA Metals Reports Assays from R-0061 to R-0063 with Intercepts Including 47.36% Fe2O3, 6.73% TiO2, 0.353% V2O5 from 2026 Drilling at Radar Critical Minerals Project in Labrador
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share